Nakajima Y, Howells R D, Pegg C, Jones E D, Smith B R
Endocrine Immunology Unit, University of Wales College of Medicine, Cardiff, U.K.
Mol Cell Endocrinol. 1987 Sep;53(1-2):15-23. doi: 10.1016/0303-7207(87)90187-0.
The interaction between thyroid microsomal autoantibodies and thyroid microsomal antigen/thyroid peroxidase (TPO) has been studied using both intact antigen preparations and their water-soluble trypsin fragments. In an analysis of sera from 30 patients with Graves' or Hashimoto's diseases, microsomal antibodies showed similar reactivity towards trypsin fragments (with TPO activity) and intact detergent (sodium deoxycholate, DOC)-solubilized human microsomal antigen preparations (r = 0.96). This raised the possibility that both the peroxidase-active site and the major autoantigenic site(s) of microsomal antigen were present on the same trypsin fragments. Studies with porcine TPO showed that only a few sera contained microsomal antibodies which cross-reacted strongly with the porcine preparations. Further analysis was carried out by immunoprecipitation of 125I-labelled microsomal antigen followed by SDS-PAGE and autoradiography. These studies suggest that intact human microsomal antigen (a single-chain protein with Mr = 110,000) contains an intrachain loop of amino acids formed by a disulphide bridge. Trypsin treatment cleaves the antigen close to its transmembrane section and releases a water-soluble fragment (Mr = 100,000), containing the intact disulphide-linked loop of amino acids. Further trypsin action causes cleavage of the peptide bonds within the loop in some preparations. Consequently, three major water-soluble trypsin fragments (Mr = 100,000, 73,000 and 68,000) are formed all of which contain an intact disulphide bridge and have microsomal antibody binding activities. The integrity of the disulphide bridge in intact antigen/TPO preparations and their trypsin fragments is essential for autoantibody binding activity.
已使用完整抗原制剂及其水溶性胰蛋白酶片段研究了甲状腺微粒体自身抗体与甲状腺微粒体抗原/甲状腺过氧化物酶(TPO)之间的相互作用。在对30例格雷夫斯病或桥本氏病患者血清的分析中,微粒体抗体对胰蛋白酶片段(具有TPO活性)和完整去污剂(脱氧胆酸钠,DOC)溶解的人微粒体抗原制剂表现出相似的反应性(r = 0.96)。这增加了微粒体抗原的过氧化物酶活性位点和主要自身抗原位点都存在于相同胰蛋白酶片段上的可能性。对猪TPO的研究表明,只有少数血清含有与猪制剂强烈交叉反应的微粒体抗体。通过对125I标记的微粒体抗原进行免疫沉淀,然后进行SDS-PAGE和放射自显影进行了进一步分析。这些研究表明,完整的人微粒体抗原(一种Mr = 110,000的单链蛋白)包含由二硫键形成的氨基酸链内环。胰蛋白酶处理在靠近其跨膜部分处切割抗原,并释放出一个水溶性片段(Mr = 100,000),该片段包含完整的二硫键连接的氨基酸环。在某些制剂中,进一步的胰蛋白酶作用会导致环内肽键的断裂。因此,形成了三个主要的水溶性胰蛋白酶片段(Mr = 100,000、73,000和68,000),所有这些片段都包含完整的二硫键并具有微粒体抗体结合活性。完整抗原/TPO制剂及其胰蛋白酶片段中二硫键的完整性对于自身抗体结合活性至关重要。